COMPARISON OF HEALTHCARE COSTS AND RESOURCE UTILIZATION FOR OVERACTIVE BLADDER PATIENTS IN THE UNITED STATES PERSISTING WITH MIRABEGRON TREATMENT OR SWITCHING TO ONABOTULINUMTOXINA

被引：0
|
作者：
Ng, D. B. [1 ]
Espinosa, R. [2 ]
Johnson, S. [2 ]
Walker, D. [1 ]
Gooch, K. [1 ]
机构：
[1] Astellas Pharma Global Dev, Northbrook, IL USA
[2] Medicus Econ LLC, Milton, MA USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2017年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
481
引用
收藏
页码：S362 / S363
页数：2
相关论文
共 50 条
  • [1] The impact of persistence with mirabegron usage vs switching to onabotulinumtoxinA on healthcare costs and resource utilization in patients with overactive bladder in the United States
    Bin Ng, Daniel
    Espinosa, Robert
    Johnson, Scott J.
    Walker, David
    Gooch, Katherine
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (12) : 1272 - 1280
  • [2] Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison
    Freemantle, Nick
    Ginsberg, David A.
    McCool, Rachael
    Fleetwood, Kelly
    Arber, Mick
    Khalaf, Kristin
    Loveman, Clara
    Ni, Quanhong
    Glanville, Julie
    BMJ OPEN, 2016, 6 (02):
  • [3] Resource use and healthcare costs in patients with overactive bladder who initiate treatment with mirabegron or antimuscarinic monotherapy in Catalonia: the MIRACAT study
    de Almeida, R. Martins
    Mateu Arrom, L.
    Ortiz Nunez, A.
    Covernton, P. J. O.
    Mora Blazquez, A. M.
    ACTAS UROLOGICAS ESPANOLAS, 2022, 46 (03): : 184 - 192
  • [4] Cost and resource utilization in frail patients with overactive bladder treated with mirabegron or an antimuscarinic
    Walker, D.
    Johnson, T. M.
    Kimura, T.
    Nimke, D.
    Jiang, B.
    Lozano-Ortega, G.
    Lockefeer, A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S140 - S140
  • [5] TREATMENT NAVIGATOR IMPACT ON UTILIZATION OF ONABOTULINUMTOXINA AS THIRD LINE TREATMENT IN OVERACTIVE BLADDER: A RETROSPECTIVE DATABASE STUDY IN THE UNITED STATES
    Enemchukwu, E.
    Miles-Thomas, J.
    Syan, R.
    Abraham, N.
    Madaj, K.
    Spenta, Anson K.
    Boroujerdi, A.
    Bai, Z.
    Luo, L.
    Newman, D.
    NEUROUROLOGY AND URODYNAMICS, 2021, 40 : S98 - S99
  • [6] Healthcare Resource Utilization and Cost of Overactive Bladder among the Medically Complex Vulnerable Elderly in the United States
    Chuang, C.
    Yang, E.
    Zou, K.
    Araiza, A.
    Wang, A.
    Luo, X.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S72 - S72
  • [7] Healthcare resource utilization and costs for patients with postoperative atrial fibrillation in the United States
    Park, Tae Jin
    Hansen, Ryan
    Gillard, Patrick
    Shah, Darshini
    Ferguson, William G.
    Piccini, Jonathan
    Romano, Matthew A.
    Devine, Beth
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1417 - 1423
  • [8] OVERACTIVE BLADDER IN THE UNITED STATES LONGTERM CARE SETTING IS ASSOCIATED WITH SIGNIFICANT BURDEN AND INCREASED HEALTHCARE RESOURCE UTILIZATION AND COSTS: A RETROSPECTIVE DATABASE STUDY
    Yeaw, J.
    Shah, D.
    Kincaid, A.
    Mudd, P. N., Jr.
    VALUE IN HEALTH, 2020, 23 : S377 - S378
  • [9] Mirabegron and antimuscarinic use in frail overactive bladder patients in the United States Medicare population
    Johnson, Theodore M., II
    Walker, David
    Lockefeer, Amy
    Jiang, Baoguo
    Nimke, David
    Lozano-Ortega, Greta
    Kimura, Tomomi
    NEUROUROLOGY AND URODYNAMICS, 2022, 41 (08) : 1872 - 1889
  • [10] Healthcare Resource Utilization and Costs Among Patients With Stroke -related Spasticity Before and After Treatment With OnabotulinumtoxinA
    Bloudek, Lisa
    Migliaccio-Walle, Kristen
    Oliveri, David
    Tung, Amy
    Gillard, Patrick
    NEUROLOGY, 2022, 98 (18)
12345